cilomilast has been researched along with clarithromycin in 2 studies
Studies (cilomilast) | Trials (cilomilast) | Recent Studies (post-2010) (cilomilast) | Studies (clarithromycin) | Trials (clarithromycin) | Recent Studies (post-2010) (clarithromycin) |
---|---|---|---|---|---|
162 | 13 | 42 | 7,149 | 1,606 | 2,504 |
Protein | Taxonomy | cilomilast (IC50) | clarithromycin (IC50) |
---|---|---|---|
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 5.5 | |
Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 3.3113 | |
Solute carrier organic anion transporter family member 1B1 | Homo sapiens (human) | 3.0903 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
2 other study(ies) available for cilomilast and clarithromycin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |